PubMed Health⌕ Search

Biomedical subjects

K Enslein

Publications and source records attributed to K Enslein.

6 recordsLinked to original sources
PubMed1991

Estimation of maximum tolerated dose for long-term bioassays from acute lethal dose and structure by QSAR.

A quantitative structure-activity relationship (QSAR) model has been developed to estimate maximum tolerated doses (MTD) from structural features of chemicals and the corresponding oral acute lethal doses (LD50) as determined in male rats. The model is based on a set of 269 diverse chemicals which have been tested under the National Cancer Institute/National Toxicology Program (NCI/NTP) protocols. The rat oral LD50 value was the strongest predictor. Additionally, 22 structural descriptors comprising nine substructural MOLSTAC(c) keys, three molecular connectivity indices, and sigma charges on 10 molecular fragments were identified as endpoint predictors. The model explains 76% of the variance and is significant (F = 35.7) at p less than 0.0001 with a standard error of the estimate of 0.40 in the log (1/mol) units used in Hansch-type equations. Cross-validation showed that the difference between the average deleted residual square (0.179) and the model residual square (0.160) was not significant (t = 0.98).

Animals↗
PubMed1990

Salmonella mutagenicity and rodent carcinogenicity: quantitative structure-activity relationships.

Based on a compilation of 222 reports of rodent nominal lifetime carcinogenicity bioassays by the NCI/NTP on the one hand, and corresponding Salmonella mutagenicity bioassays (Ames tests) on the other, Ashby and Tennant (1988) have divided the carcinogens and non-carcinogens into genotoxic (Ames test positive) and non-genotoxic (Ames test negative) groups and discussed structural characteristics common to each of these groups. The Ames test alone was deemed to be adequate for the identification of genotoxicity because other short-term bioassays, and even combinations, or batteries, appeared to offer no significant advantages. From the results of this study it is possible to achieve (1) a division of the carcinogens into the same genotoxic and non-genotoxic groups, and (2) a division of the non-genotoxic compounds into the same carcinogenic and non-carcinogenic groups, solely on the basis of structure-activity relationships, with a classification accuracy of approx. 95%. (1) An equation comprising 8 sigma molecular charge descriptors, 2 molecular connectivity indices (MCIs), 2 kappa molecular shape descriptors and one MOLSTAC substructure descriptor achieved discrimination between genotoxic and non-genotoxic carcinogens with an accuracy of 94.5%. (2) Another equation comprising 8 sigma molecular charge descriptors, 3 MCIs, one kappa shape descriptor and 12 substructural descriptors achieved discrimination between non-genotoxic carcinogens and non-genotoxic non-carcinogens with an accuracy of 95.2%. These SAR models are suitable for the distinction between (1) genotoxic and non-genotoxic carcinogens and (2) carcinogenic and non-carcinogenic non-genotoxins, both in the absence of animal bioassay data.

Carcinogenicity Tests↗
PubMedDate not supplied

A toxicity estimation model.

A statistical model has been developed for estimation of acute toxicity. The model, currently operational for rat oral LD50, permits the estimation of rat oral LD50 for untested chemical compounds. Only the chemical structure, partition coefficient, and molecular weight for a compound are needed for estimation purposes. The chemical structure is partitioned into substructural fragments using the CIDS fragment keys. A regression model is developed on the basis of 425 compounds. A test of the regression equation with 100 compounds not used in its design shows that 56 percent of the compounds are predicted with less than 0.4 log unit deviation between extimated and measured LD50. This toxicity estimation model can be readily adapted to other species and to other measures of toxicity by the use of suitable design data bases. The model also identifies the contribution to toxicity of the fragments and physical characteristics. The use of this model can materially reduce the amount of toxicological testing for new compounds. It also permits the ranking of potentially toxic compounds to allow the most likely candidates to be tested. The method may also prove applicable to the determination of optimum dosages for new drugs.

Animals↗